DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. With this investment, we look forward to helping Cleerly expand its reach and impact, bringing this potentially life-saving innovation to more patients and health systems nationally.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Technology Plaque 52

DAIC

MARCH 20, 2024

“Biotronik 's focus on vascular interventional excellence is evident in our strategic investments and persistent dedication to innovation”, said Dr. Jörg Pochert, President of Vascular Intervention at Biotronik. For more information: www.biotronik.com References: 1 Kwong M.,

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. 301–302, [link]. 3 Secemsky, Eric A.,

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. The DynamX bioadaptor has a novel design and mechanism of action designed to return the diseased vessel to a more normal condition, through three distinct phases.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

DAIC

JANUARY 3, 2024

With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes. 3 HeartFlow’s FFR CT Analysis is covered by Medicare and for >99% of commercially insured lives.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

MARCH 7, 2024

I think especially with the recent changes in guidelines and the recommendation to use CT for screening of coronary artery disease, we expect to see this trend really impact the way CT is used in the future.” “The CT procedural mix is evolving, and cardiac CT is starting to account for a large proportion of that.

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

Wellnest

JUNE 19, 2023

The development has urged us to integrate the latest Artificial Intelligence with the healthcare system, including Cardiac Medicare. With the continued evolution of AI, it is now being introduced in cardiac healthcare, promising opportunities for innovation and advancements in cardiovascular medicine. What is Artificial Intelligence?

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52